3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine

C71H76N30OS2 — CID 158201699

IUPAC3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine
SMILESCc1cc(Nc2nc(C3CCCNC3)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1noc(C)c1Nc1nccn2c(-c3cnn(C)c3)cnc12.Cn1cc(-c2cnc3c(Nc4cc(C5CCCNC5)ns4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5c(c4)CC(N)C5)nccn23)cn1
InChIInChI=1S/C19H22N8S.C19H19N7.C18H20N8S.C15H15N7O/c1-12-6-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-4-3-5-20-7-13;1-25-11-14(9-23-25)17-10-22-19-18(21-4-5-26(17)19)24-16-3-2-12-6-15(20)7-13(12)8-16;1-25-11-13(9-22-25)15-10-21-18-17(20-5-6-26(15)18)23-16-7-14(24-27-16)12-3-2-4-19-8-12;1-9-13(10(2)23-20-9)19-14-15-17-7-12(22(15)5-4-16-14)11-6-18-21(3)8-11/h6,8-11,13,20H,3-5,7H2,1-2H3,(H,23,24);2-5,8-11,15H,6-7,20H2,1H3,(H,21,24);5-7,9-12,19H,2-4,8H2,1H3,(H,20,23);4-8H,1-3H3,(H,16,19)
InChIKeyGBAAUYBMAPTEKA-UHFFFAOYSA-N
MW1429.73 g/mol
LogP10.68
Rot. Bonds14

About 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine

3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine (PubChem CID 158201699) has the molecular formula C71H76N30OS2 and a molecular weight of 1429.73 g/mol. Its IUPAC name is 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine.

Molecular Properties

Compound Name3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine
PubChem CID158201699
Molecular FormulaC71H76N30OS2
Molecular Weight1429.73 g/mol
Exact Mass1428.63
IUPAC Name3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine
SMILESCc1cc(Nc2nc(C3CCCNC3)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1noc(C)c1Nc1nccn2c(-c3cnn(C)c3)cnc12.Cn1cc(-c2cnc3c(Nc4cc(C5CCCNC5)ns4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5c(c4)CC(N)C5)nccn23)cn1
InChIInChI=1S/C19H22N8S.C19H19N7.C18H20N8S.C15H15N7O/c1-12-6-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-4-3-5-20-7-13;1-25-11-14(9-23-25)17-10-22-19-18(21-4-5-26(17)19)24-16-3-2-12-6-15(20)7-13(12)8-16;1-25-11-13(9-22-25)15-10-21-18-17(20-5-6-26(15)18)23-16-7-14(24-27-16)12-3-2-4-19-8-12;1-9-13(10(2)23-20-9)19-14-15-17-7-12(22(15)5-4-16-14)11-6-18-21(3)8-11/h6,8-11,13,20H,3-5,7H2,1-2H3,(H,23,24);2-5,8-11,15H,6-7,20H2,1H3,(H,21,24);5-7,9-12,19H,2-4,8H2,1H3,(H,20,23);4-8H,1-3H3,(H,16,19)
InChIKeyGBAAUYBMAPTEKA-UHFFFAOYSA-N
XLogP10.68
TPSA342.05 Ų
H-Bond Donors7
H-Bond Acceptors33
Rotatable Bonds14
Heavy Atoms104
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001429.73
LogP ≤ 510.68
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1033

Analyze 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine?
The IUPAC name of 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine (CID 158201699) is 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine.
What is the SMILES notation for 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine?
The canonical SMILES for 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine is Cc1cc(Nc2nc(C3CCCNC3)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1noc(C)c1Nc1nccn2c(-c3cnn(C)c3)cnc12.Cn1cc(-c2cnc3c(Nc4cc(C5CCCNC5)ns4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4ccc5c(c4)CC(N)C5)nccn23)cn1.
What is the InChIKey of 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine?
The InChIKey is GBAAUYBMAPTEKA-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H22N8S.C19H19N7.C18H20N8S.C15H15N7O/c1-12-6-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-4-3-5-20-7-13;1-25-11-14(9-23-25)17-10-22-19-18(21-4-5-26(17)19)24-16-3-2-12-6-15(20)7-13(12)8-16;1-25-11-13(9-22-25)15-10-21-18-17(20-5-6-26(15)18)23-16-7-14(24-27-16)12-3-2-4-19-8-12;1-9-13(10(2)23-20-9)19-14-15-17-7-12(22(15)5-4-16-14)11-6-18-21(3)8-11/h6,8-11,13,20H,3-5,7H2,1-2H3,(H,23,24);2-5,8-11,15H,6-7,20H2,1H3,(H,21,24);5-7,9-12,19H,2-4,8H2,1H3,(H,20,23);4-8H,1-3H3,(H,16,19).
What are the key properties of 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine?
3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine has a molecular weight of 1429.73 g/mol, XLogP of 10.68, 14 rotatable bonds, 7 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 3,5-dimethyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-oxazol-4-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-piperidin-3-ylimidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;5-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-2,3-dihydro-1H-indene-2,5-diamine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-piperidin-3-yl-1,2-thiazol-5-amine is sourced from PubChem (CID 158201699), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).